<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38601833</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2472-2448</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>Psychopharmacology bulletin</Title><ISOAbbreviation>Psychopharmacol Bull</ISOAbbreviation></Journal><ArticleTitle>Case Report on High Dose Lithium Treatment for Post-COVID Depression, Recurrent Fevers, and Skin Lesions.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>45</EndPage><MedlinePgn>39-45</MedlinePgn></Pagination><Abstract><AbstractText>This is a case of a 35-year-old woman who presented with an 18-month history of post (long)-COVID depression and exhaustion along with recurrent fevers and treatment-resistant skin boils, all of which abated with lithium treatment at a serum level of 1.14 mmol/L, and all of which worsened when the lithium serum level was lowered to 0.8. This paper illustrates Lithium's effectiveness in the treatment of post (long)-COVID syndrome, though a higher serum concentration may be required.</AbstractText><CopyrightInformation>Copyright &#xa9; 1964&#x2013;2024 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Massoumi</LastName><ForeName>Lila Elizabeth</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Massoumi, MD, Michigan State University, Integrative Psychiatry Services, PC, Bingham Farms, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenbaum</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rosenbaum, MD, Wayne State University, West Bloomfield, MI.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychopharmacol Bull</MedlineTA><NlmUniqueID>0101123</NlmUniqueID><ISSNLinking>0048-5764</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018020">Lithium Compounds</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="Y">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018020" MajorTopicYN="N">Lithium Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">depressive disorder</Keyword><Keyword MajorTopicYN="N">fever</Keyword><Keyword MajorTopicYN="N">furunculosis</Keyword><Keyword MajorTopicYN="N">lithium carbonate</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38601833</ArticleId><ArticleId IdType="pmc">PMC11003256</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis . 2022;22(4):e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, Kang JH, Weisskopf MG, Branch-Elliman W, Roberts AL. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post&#x2013;COVID-19 conditions. JAMA Psychiatry . 2022;79(11):1081&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazumi M, Usuda K, Okazaki E, Kataoka M, Nishi D. Differences in the course of depression and anxiety after COVID-19 infection between recovered patients with and without a psychiatric history: A cross-sectional study. Int J Environ Res Public Health . 2022;19(18):11316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9517442</ArticleId><ArticleId IdType="pubmed">36141588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK. Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19. New England Journal of Medicine . 2022;387(7):599&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9945922</ArticleId><ArticleId IdType="pubmed">36070710</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochwerg B, Agoritsas T, Lamontagne FC, Leo YS, Macdonald H, Agarwal A, Zeng L, Lytvyn L, Appiah JA, Amin W, Arabi Y. A living WHO guideline on drugs for COVID-19. BMJ . 2020;370</Citation><ArticleIdList><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdool Karim SS, Devnarain N. Time to stop using ineffective COVID-19 drugs. N Engl J Med . 2022;387(7):654&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pubmed">36070715</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita Y, Yamamoto S, Nagata M, Ogasawara N, Hasegawa S. Long COVID presenting with intermittent fever after COVID-19 pneumonia. Radiology Case Reports . 2021;16(9):2478&#x2013;2481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175804</ArticleId><ArticleId IdType="pubmed">34104285</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman EE, McMahon DE, Fitzgerald ME, Fox LP, Rosenbach M, Takeshita J, French LE, Thiers BH, Hruza GJ. The American academy of dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19. J Am Acad Dermatol . 2020;83(2):509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162762</ArticleId><ArticleId IdType="pubmed">32305438</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner GR, Hartley CE, Buchan A, Harper L, Gallimore P. The effect of lithium chloride on the replication of herpes simplex virus. Medical Microbiology and Immunology . 1980;168(2):139&#x2013;148. doi: 10.1007/BF02121762. doi: PMID: 6256617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02121762</ArticleId><ArticleId IdType="pubmed">6256617</ArticleId></ArticleIdList></Reference><Reference><Citation>Murru A, Manchia M, Hajek T, Nielsen RE, Rybakowski JK, Sani G, Schulze TG, Tondo L, Bauer M International Group for The Study of Lithium Treated Patients (IGSLi) Lithium&#x2019;s antiviral effects: A potential drug for COVID-19 disease. International Journal of Bipolar Disorders . 2020;8(1):1&#x2013;9. doi: 10.1186/s40345-020-00191-4. doi: PMID: 32435920; PMCID: PMC7239605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40345-020-00191-4</ArticleId><ArticleId IdType="pmc">PMC7239605</ArticleId><ArticleId IdType="pubmed">32435920</ArticleId></ArticleIdList></Reference><Reference><Citation>De Picker LJ, Leboyer M, Geddes JR, Morrens M, Harrison PJ, Taquet M. Association between serum lithium level and incidence of COVID-19 infection. The British Journal of Psychiatry . 2022;221(1):425&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612897</ArticleId><ArticleId IdType="pubmed">35318909</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Verma A, Garcia G, Jr, Ramage H, Lucas A, Myers RL, Michaelson JJ, Coryell W, Kumar A, Charney AW, Kazanietz MG. Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition. Proceedings of the National Academy of Sciences . 2021;118(42):e2113401118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8594528</ArticleId><ArticleId IdType="pubmed">34593624</ArticleId></ArticleIdList></Reference><Reference><Citation>Spuch C, L&#xf3;pez-Garc&#xed;a M, Rivera-Baltan&#xe1;s T, Cabrera-Alvargonz&#xe1;lez JJ, Gadh S, Rodrigues-Amorim D, &#xc1;lvarez-Est&#xe9;vez T, Mora A, Iglesias-Mart&#xed;nez-Almeida M, Freir&#xed;a-Mart&#xed;nez L, P&#xe9;rez-Rodr&#xed;guez M. Efficacy and safety of lithium treatment in SARS-CoV-2 infected patients. Front Pharmacol . 2022;13:1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046673</ArticleId><ArticleId IdType="pubmed">35496309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaidanovich-Beilin O, Woodgett JR. GSK-3: Functional insights from cell biology and animal models. Frontiers in Molecular Neuroscience . 2011;4:40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3217193</ArticleId><ArticleId IdType="pubmed">22110425</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano-Torres O, Romero EN, Sosa NG, Puertas JE, Quintero AF, Montero MG, Alfonso DM, Hernandez YI, Lastre M, Rodr&#xed;guez-P&#xe9;rez L, Borrego Y. Lithium salts as a treatment for COVID-19: Pre-clinical outcomes. Biomed Pharmacother . 2022;149:112872. doi: 10.1016/j.biopha.2022.112872. doi: Epub 2022 Mar 25. PMID: 35364381; PMCID: PMC8947939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.112872</ArticleId><ArticleId IdType="pmc">PMC8947939</ArticleId><ArticleId IdType="pubmed">35364381</ArticleId></ArticleIdList></Reference><Reference><Citation>Rybakowski JK, Amsterdam JD. Lithium prophylaxis and recurrent labial herpes infections. Lithium . 1991;2:43&#x2013;47.</Citation></Reference><Reference><Citation>Kushner I, Samols D, Magrey M. A unifying biologic explanation for &#x201c;high-sensitivity&#x201d; C-reactive protein and &#x201c;low-grade&#x201d; inflammation. Arthritis Care &amp; Research . 2010;62(4):442&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">20391496</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation . 2003;107(3):499&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">12551878</ArticleId></ArticleIdList></Reference><Reference><Citation>Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nature Clinical Practice Cardiovascular Medicine . 2008;5(10):621&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2639398</ArticleId><ArticleId IdType="pubmed">18711404</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Luo R, Zhang S, Liu Y, Wang Y, Feng S, Li H. C-reactive protein could predict the efficacy of SSRIs in clinical practice: A cohort study of large samples in the real world. Journal of Affective Disorders . 2022;313:251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">35772630</ArticleId></ArticleIdList></Reference><Reference><Citation>Halaris A, Prochaska D, Stefanski A, Filip M. C-reactive protein in major depressive disorder: Promise and challenge. Journal of Affective Disorders Reports . 2022;10:100427.</Citation></Reference><Reference><Citation>Zhang Y, Wang J, Ye Y, Zou Y, Chen W, Wang Z, Zou Z. Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry . 2023:110740.</Citation><ArticleIdList><ArticleId IdType="pubmed">36893912</ArticleId></ArticleIdList></Reference><Reference><Citation>Queissner R, Lenger M, Birner A, Dalkner N, Fellendorf F, Bengesser S, Platzer M, Hamm C, Maget A, Reininghaus B, Ratzenhofer M. The association between anti-inflammatory effects of long-term lithium treatment and illness course in Bipolar Disorder. J Affect Disord . 2021;281:228&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">33338840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Goodman DB, Kamoun M, Amsterdam JD. Positive and negative acute phase proteins in affective subtypes. Journal of Affective Disorders . 1998;49(1):9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">9574855</ArticleId></ArticleIdList></Reference><Reference><Citation>Queissner R, Pilz R, Dalkner N, Birner A, Bengesser SA, Platzer M, Fellendorf FT, Kainzbauer N, Herzog-Eberhard S, Hamm C, Reininghaus B. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder. Psychoneuroendocrinology . 2018;90:61&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">29433074</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwanwongse K, Shabarek N. Lithium toxicity in two coronavirus disease 2019 (COVID-19) patients. Cureus . 2020;12(5):e8384. doi: 10.7759/cureus.8384. doi: PMID: 32637266; PMCID: PMC7331926.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8384</ArticleId><ArticleId IdType="pmc">PMC7331926</ArticleId><ArticleId IdType="pubmed">32637266</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai NM, Malyam V, Murugesan M, Ganjekar S, Moirangthem S, Desai G. Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: A case series and possible mechanisms. International Clinical Psychopharmacology . 2022;37(1):25&#x2013;28. doi: 10.1097/YIC.0000000000000379. doi: PMID: 34686643; PMCID: PMC8635074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YIC.0000000000000379</ArticleId><ArticleId IdType="pmc">PMC8635074</ArticleId><ArticleId IdType="pubmed">34686643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>